Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

StoneX (SNEX) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for StoneX (SNEX) over the last 16 years, with Q4 2025 value amounting to $1.2 million.

  • StoneX's Asset Writedowns and Impairment fell 3333.33% to $1.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 million, marking a year-over-year decrease of 740.74%. This contributed to the annual value of $3.1 million for FY2025, which is 41666.67% up from last year.
  • According to the latest figures from Q4 2025, StoneX's Asset Writedowns and Impairment is $1.2 million, which was down 3333.33% from $800000.0 recorded in Q3 2025.
  • StoneX's Asset Writedowns and Impairment's 5-year high stood at $12.3 million during Q1 2022, with a 5-year trough of -$700000.0 in Q2 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $2.3 million, with a median of $850000.0 in 2021.
  • Within the past 5 years, the most significant YoY rise in StoneX's Asset Writedowns and Impairment was 126666.67% (2022), while the steepest drop was 15384.62% (2022).
  • StoneX's Asset Writedowns and Impairment (Quarter) stood at -$200000.0 in 2021, then soared by 450.0% to $700000.0 in 2022, then plummeted by 142.86% to -$300000.0 in 2023, then soared by 700.0% to $1.8 million in 2024, then plummeted by 33.33% to $1.2 million in 2025.
  • Its Asset Writedowns and Impairment stands at $1.2 million for Q4 2025, versus $800000.0 for Q3 2025 and $400000.0 for Q2 2025.